The Angioplasty Balloons Market is evolving as hospitals and cardiovascular care centers adopt increasingly sophisticated tools for minimally invasive vascular procedures. Improvements in balloon construction and catheter technology are helping expand the range of applications for these devices.

Market Research Future reports that the global market reached approximately USD 3.38 billion in 2024 and is forecast to grow to USD 5.1 billion by 2035. The expected CAGR for 2025–2035 is 3.81%.

Drug-eluting balloons represent an important product category, combining balloon angioplasty with localized drug delivery. Scoring balloons are another developing segment, offering specialized mechanical features for certain procedures.

The industry is also benefiting from the broader shift toward minimally invasive treatment. Compared with more invasive surgical approaches, catheter-based procedures can provide healthcare professionals with alternative ways to address vascular narrowing. This trend is encouraging continued investment in balloon design and delivery systems.

Hospitals remain a key end-user group because they provide the infrastructure and specialist teams required for complex cardiovascular procedures. However, ambulatory surgical centers are gaining importance as healthcare systems increasingly explore efficient outpatient treatment models.

Future development will likely depend on product innovation, regulatory compliance, healthcare spending, and the ability of manufacturers to address changing clinical requirements. These factors are expected to shape competition and investment across the angioplasty balloons industry.

Gain a competitive edge with insightful market reports:

Ureteral Stents Market Share

Artificial Intelligence In Precision Medicine Market Trends

Lupin Market Growth

Tissue Banking Market Demand

Bronchodilators Market Volume